Vivek Ahuja | Senior Vice President, Global Delivery Excellence, Strategy & Growth, PV, Quality & Regulatory Service Lines
Eversana

A physician by education with training in business administration and a seasoned professional in the pharmaceutical industry, Dr. Vivek Ahuja pioneered the introduction of pharmacovigilance as a subject and science in India in the year 2003. With his vision he established the country’s first global pharmacovigilance unit in Ranbaxy and scaled up several such organizations in this field. He has more than twenty-two years of experience spanning over diverse areas like pharmacovigilance, clinical research, public health and technology. With experience in working in worldwide pharmacovigilance regulations related to drugs, vaccines and devices and having worked closely with several global regulatory authorities on technology related aspects, Vivek brings hands on experience and insights in these areas. He currently works for Eversana as Senior Vice President for Delivery excellence, strategy and growth for the pharmacovigilance, regulatory and quality businesses.
Prior to joining Eversana, Dr. Vivek Ahuja was Vice President – Medical Affairs & Global Head of Pharmacovigilance at SunPharma the fourth largest generic company globally. His responsibilities include managing the Global Pharmacovigilance function with teams from US, EU, Japan, South Africa and India supporting him to maintain compliance to global regulations. Prior to this, he worked at a global technology company i.e. ArisGlobal, where he was Vice President for Global Pharmacovigilance and headed the safety business unit. His responsibilities included strategy, operations, managing the profit and loss of this software technology business. Prior to joining ArisGlobal, Vivek worked as Director, Research and Development at PATH. He was overseeing PATH’s work of driving transformative global health innovation to save and improve lives, through multiple projects involving public health and vaccine safety. PATH is a Seattle based international nonprofit organization working to accelerate health equity and also the world’s largest public health partner to the Bill & Melinda Gates foundation. Dr. Ahuja is a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Government Medical College, Chandigarh, India and subsequently did his MD from All India Institute of Medical Sciences, New Delhi. He is also an Executive MBA (Post Graduate Diploma in Business Management) from one of the leading Business Schools in India (Management Development Institute, Gurgaon). Vivek actively contributes to policy making for the government. In particular, he co-authored the Pharmacovigilance Program of India (Government of India) in 2010 and supported the Nepal and Bangladesh governments by conceptualizing focused pharmacovigilance programs for neglected drugs. In China, he helped establish the vaccine safety systems of the largest government vaccine manufacturer. He has avid interest in technology and its applications particularly cognitive computing.